Trial site
The Affiliated Cancer Hospital of Guizhou Medical University
Guiyang, Guizhou 550000, ChinaNot linked to an institution yet
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Sichuan Baili Pharmaceutical Co., Ltd.2 trials
- Guizhou Medical University1 trial
- Hoffmann-La Roche1 trial
- JIANGSU SHENMING Medical Technology CO., Ltd1 trial
- and 1 more
Running trials
Not yet recruiting
Clinical Study of Ivonescimab Combined With Concurrent Chemoradiotherapy in the Treatment of Advanced Non-small Cell Lung Cancer
NCT07936578· Phase 2· Guizhou Medical University· Source
Contact: Weiwei Ouyang, MD
Recruiting
Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer
NCT07356531· JIANGSU SHENMING Medical Technology CO., Ltd· Source
Contact: Wei He, associate chief physician
Recruiting
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
NCT05862337· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Contact: Xing Wang, Doctor
Recruiting
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
NCT05744687· Phase 2/3· Shanghai Pharmaceuticals Holding Co., Ltd· Source
Contact: Zhihong Wang
Active, not recruiting
A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC
NCT05054439· Phase 2· Sichuan Baili Pharmaceutical Co., Ltd.· Source
Active, not recruiting
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
NCT05044897· Phase 2· Sichuan Baili Pharmaceutical Co., Ltd.· Source
Active, not recruiting
A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
NCT04854668· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error